Outset Medical Inc [NASDAQ: OM] traded at a low on Wednesday, posting a -4.25 loss after which it closed the day’ session at $0.83.
The results of the trading session contributed to over 2750153 shares changing hands. Over the past one week, the price volatility of Outset Medical Inc stands at 29.32% while the volatility over the past one month is 12.54%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for OM stock reached $43.39 million, with 50.32 million shares outstanding and 47.74 million shares in the current float. Compared to the average trading volume of 1.52M shares, OM reached a trading volume of 2750153 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Outset Medical Inc [OM]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OM shares is $3.18 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OM stock is a recommendation set at 2.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for Outset Medical Inc shares, keeping their opinion on the stock as Sector Perform, with their previous recommendation back on August 08, 2024. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price from $5 to $6. The new note on the price target was released on June 21, 2024, representing the official price target for Outset Medical Inc stock. Previously, the target price had yet another raise to $6, while BTIG Research analysts kept a Buy rating on OM stock.
The Average True Range (ATR) for Outset Medical Inc is set at 0.35, with the Price to Sales ratio for OM stock in the period of the last 12 months amounting to 0.37. The Price to Book ratio for the last quarter was 0.63, with the Price to Cash per share for the same quarter was set at 3.74.
How has OM stock performed recently?
Outset Medical Inc [OM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -75.50. With this latest performance, OM shares dropped by -82.72% in over the last four-week period, additionally sinking by -73.64% over the last 6 months – not to mention a drop of -94.83% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OM stock in for the last two-week period is set at 15.36, with the RSI for the last a single of trading hit 7.93, and the three-weeks RSI is set at 22.20 for Outset Medical Inc [OM]. The present Moving Average for the last 50 days of trading for this stock 3.6376, while it was recorded at 0.9149 for the last single week of trading, and 3.7058 for the last 200 days.
Outset Medical Inc [OM]: Deeper insight into the fundamentals
Outset Medical Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.38 and a Current Ratio set at 6.80.
Insider trade positions for Outset Medical Inc [OM]
The top three institutional holders of OM stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in OM stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in OM stock with ownership which is approximately 5.1238%.
